Skip to content

: SARS-CoV-2 (COVID-19) Intubation Status/Progress Qualitative Test

Published: August 9, 2026Updated: August 16, 2026

: This test relates to monitoring a patient's status and progress around intubation (breathing tube placement) in the context of COVID-19. It is used to help track respiratory support needs during severe COVID-19 illness.

Quick summary

[": This test helps document and track a COVID-19 patient's intubation status and respiratory progress."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
100458-9
Short code
OP COVID-19 Intub+Progress
Synonyms
OP COVID-19 Intub+Progress
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
role
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

: What This Test Relates To

: This entry relates to assessing and documenting the status of intubation—placement of a breathing tube—in patients with COVID-19. It reflects respiratory support decision-making during severe illness rather than measuring a specific chemical substance in the blood.

: Why It May Be Used

: Clinicians may use this information to track whether a COVID-19 patient requires, is undergoing, or has been weaned from mechanical ventilation. It supports communication among care teams about a patient's respiratory trajectory.

: How Results Are Interpreted

: Because this is a status/progress descriptor rather than a numeric lab value, results are typically expressed as a qualitative category or status (for example, reflecting intubation state). Your care team interprets it alongside oxygen levels, imaging, and overall clinical picture.

: Important Limitations

: This test does not by itself diagnose or exclude COVID-19 infection. It is a supportive descriptor of respiratory status and should always be interpreted in the full clinical context by the treating team.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

: Intubation status monitoring is clinically significant in severe COVID-19 because timely respiratory support and weaning decisions strongly influence patient outcomes. Documenting intubation progress helps coordinate critical care and rehabilitation planning.

Short name

: COVID-19 Intubation Progress

Frequently asked questions

: Does this test diagnose COVID-19?
: No. This test relates to tracking intubation status and respiratory progress; it does not itself diagnose COVID-19 infection.
: Will I get a numeric result?
: Typically not. This is a status/progress descriptor, so results are usually categorical rather than numeric. Your care team will explain what the result means for your situation.
: Is intubation always required with COVID-19?
: No. Many patients with COVID-19 do not need intubation. It is used when respiratory support with oxygen or other noninvasive measures is insufficient.
  1. 1
    MedlinePlus — Laboratory TestsSource
  2. 2
    Lab Tests OnlineSource
  3. 3
    Mayo Clinic — Tests & ProceduresSource

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy